DYN compared with RVTY: revenue, margins and what each company keeps, and the suppliers and customers both name

DYNDyne Therapeutics, Inc.

Mkt capRevenueRevenue

RVTYRevvity, Inc.

Mkt capRevenueRevenue

Compare

DYNDyne Therapeutics, Inc.

RVTYRevvity, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

DYNDyne Therapeutics, Inc.

16.69▼−2.07%· post 16.69

Mkt cap$3.1BRevenue—Revenue—

RVTYRevvity, Inc.

156.81▼−5.41%· post 160.75

ClosedOct 30 '26

Mkt cap$17.5BRevenue$730MQ2 FY26Revenue$2.9BFY25

Compare

ClosedOct 30 '26

DYNDyne Therapeutics, Inc.

RVTYRevvity, Inc.

16.69▼−2.07%post 16.69

Price

156.81▼−5.41%post 160.75

$3.1B

Mkt cap

$17.5B

—

Revenue

$730MQ2 FY26

—

Revenue

$2.9BFY25

DYN16.69▼−2.07%vsRVTY156.81▼−5.41%ClosedOct 30 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

rebased to 0%

DYN, solidRVTY, dashed

Supply-chain overlap

Revenue flow

DYN: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only DYN 1

—University of Monsunlistedsupplier

Shared 0

No shared counterparties.

Only RVTY 1

VNRXVolitionrxsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR